Significance of antibody numbering systems in the development of antibody engineering
Human Antibodies · 2024
DOI: 10.3233/hab-230014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Antibodies, 2024. Verfasst von Riya Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Innoplexus Consulting Services Pvt Ltd, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Antibodies, Complementarity Determining Regions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
Immunotherapy has become increasingly popular in recent years for treating a variety of diseases including inflammatory, neurological, oncological, and auto-immune disorders. The significant interest in antibody development is due to the high binding affinity and specificity of an antibody against a specific antigen. Recent advances in antibody engineering have provided a different view on how to engineer antibodies in silico for therapeutic and diagnostic applications. In order to improve the clinical utility of therapeutic antibodies, it is of paramount importance to understand the various molecular properties which impact antigen targeting and its potency. In antibody engineering, antibody numbering (AbN) systems play an important role to identify the complementarity determining regions (CDRs) and the framework regions (FR). Hence, it is crucial to accurately define and understand the CDR, FR and the crucial residues of heavy and light chains that aid in the binding of the antibody to the antigenic site. Detailed understanding of amino acids positions are useful for modifying the binding affinity, specificity, physicochemical features, and half-life of an antibody. In this review, we have summarized the different antibody numbering systems that are widely used in antibody engineering and highlighted their significance. Here, we have systematically explored and mentioned the various tools and servers that harness different AbN systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innoplexus Consulting Services Pvt Ltd, Pune, Maharashtra, India.
- Innoplexus AG, Eschborn, Germany.
Zitieren
APA
Patel, R., Verma, P., Nagraj, A. K., Gavade, A., Sharma, O. P., & Patil, J. (2024). Significance of antibody numbering systems in the development of antibody engineering. Human Antibodies. https://doi.org/10.3233/hab-230014
Vancouver
Patel R, Verma P, Nagraj AK, Gavade A, Sharma OP, Patil J. Significance of antibody numbering systems in the development of antibody engineering. Human Antibodies. 2024. doi:10.3233/hab-230014
BibTeX
@article{Patel2024,
author = {Patel, Riya and Verma, Pratibha and Nagraj, Anil Kumar and Gavade, Akshata and Sharma, Om Prakash and Patil, Jaspal},
title = {Significance of antibody numbering systems in the development of antibody engineering},
journal = {Human Antibodies},
year = {2024},
doi = {10.3233/hab-230014}
}
EUVIMED